Trial Profile
An Open-Label, Randomized, 2-Part, Parallel Design Study to Characterize the Effect of Heparin on Palifermin Pharmacokinetics and the Effect of Palifermin on Heparin Pharmacodynamics in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Dec 2014
Price :
$35
*
At a glance
- Drugs Palifermin (Primary) ; Heparin
- Indications Thrombosis
- Focus Pharmacokinetics
- Sponsors Swedish Orphan Biovitrum
- 27 Feb 2009 Additional lead trial centre identified as reported by ClinicalTrials.gov, last updated 27 Feb 2009.
- 27 Feb 2009 Additional lead trial centre identified as reported by ClinicalTrials.gov, last updated 27 Feb 2009.
- 27 Feb 2009 Biovitrum added as trial sponsor and affiliate as reported by ClinicalTrials.gov.